Skip to main content

Table 4 Effect of h[Gly2]GLP-21-34 pretreatment on the intestinal morphology of weaned pigs exposed to LPSa

From: The prolonged effect of glucagon-like peptide 2 pretreatment on growth performance and intestinal development of weaned piglets

Item

Treatmentb

Pooled SEM

Contrastc

 

Control

LPS

LPS + Low GLP-2

LPS + High GLP-2

1

2

3

Duodenum

Villus height, μm

438

335

420

438

8

<0.001

<0.001

<0.001

Crypt depth, μm

242

257

264

237

3

0.094

0.415

0.027

VCR

1.81

1.31

1.60

1.85

0.04

<0.001

<0.001

<0.001

Jejunum

Villus height, μm

341

284

322

353

7

0.001

0.019

<0.001

Crypt depth, μm

210

207

227

212

3

0.708

0.017

0.477

VCR

1.63

1.38

1.43

1.67

0.03

0.005

0.607

0.002

Ileum

Villus height, μm

306

239

259

324

6

<0.001

0.041

<0.001

Crypt depth, μm

199.5

205.3

209.9

209.0

1.8

0.259

0.377

0.863

VCR

1.54

1.16

1.24

1.56

0.03

<0.001

0.237

<0.001

  1. aGLP-2 = Glucagon-like peptide 2; LPS = Escherichia coli lipopolysaccharide; VCR = Villus height/Crypt depth ratio
  2. bControl: piglets injected with sterile saline on d 14 postweaning; LPS: pigs challenged by LPS on d 14 postweaning; LPS + Low and LPS + High GLP-2: piglets pretreated with GLP-2 at doses of 2 and 10 nmol/kg BW per day for the first 7 d after weaning were challenged by LPS on d 14 postweaning. The data were obtained 24 h after injection with LPS and 15 d post-weaning
  3. cContrast: (1) control v. LPS; (2) LPS v. LPS + Low GLP-2; (3) LPS v. LPS + High GLP-2; Values are means of ten replicates